AGALACTOSYLATION OF SERUM IMMUNOGLOBULIN G AS A POTENTIAL BIOMARKER FOR HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Matsushita, Hiroshi
Nouso, Kazuhiro
Dohi, Chihiro
Miyahara, Koji
Kinugasa, Hideaki
Terasawa, Hiroyuki
Hirai, Mami
Nishimura, Shin-Ichiro
Okada, Hiroyuki
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1447
引用
收藏
页码：S1310 / S1310
页数：1
相关论文
共 50 条
  • [1] Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancer
    Lin, Sihan
    Wang, You
    Wang, Xinran
    Yan, Bin
    Lou, Weihua
    Di, Wen
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (12)
  • [2] Serum TGF-β1: A Potential Biomarker for Early Detection of Hepatocellular Carcinoma
    He, Jian
    Liu, Yang
    EBIOMEDICINE, 2016, 12 : 4 - +
  • [3] Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma
    Li, Hong
    Cui, Mei-ling
    Chen, Tao-yang
    Xie, Hai-yang
    Cui, Ying
    Tu, Hong
    Chen, Fu-hua
    Ge, Chao
    Li, Jin-jun
    TUMOR BIOLOGY, 2015, 36 (11) : 8399 - 8404
  • [4] Serum apolipoprotein-A4 is a potential biomarker of hepatocellular carcinoma in cirrhotic patients
    Pleguezuelo, M.
    Lopez-Sanchez, L.
    Llamoza, C.
    Montero, J.
    Lopez-Cillero, P.
    Ciria, R.
    Espejo, I
    Muntane, J.
    Rodriguez-Ariza, A.
    De la Mata, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 38 - 39
  • [5] Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma
    Zhang, Zhoujing
    Ge, Shengxiang
    Wang, Xiaomin
    Yuan, Quan
    Yan, Qiang
    Ye, Huiming
    Che, Yaojian
    Lin, Yanyan
    Zhang, Jun
    Liu, Pingguo
    HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 199 - 207
  • [6] Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
    Chen, Shuying
    Mao, Yinqi
    Chen, Wei
    Liu, Chenbin
    Wu, Han
    Zhang, Jingjun
    Wang, Shenghao
    Wang, Chengpan
    Lin, Yong
    Lv, Yuan
    JOURNAL OF CANCER, 2022, 13 (05): : 1410 - 1417
  • [7] Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
    Maeda, Takahiro
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Ao, Junjie
    Kanayama, Kengo
    Maruta, Susumu
    Kusakabe, Yuko
    Saito, Tomoko
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Nakagawa, Ryo
    Muroyama, Ryosuke
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    BMC CANCER, 2019, 19 (01)
  • [8] Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
    Asazawa, Hitomi
    Kamada, Yoshihiro
    Takeda, Yuri
    Takamatsu, Shinji
    Shinzaki, Shinichiro
    Kim, Youkoku
    Nezu, Riichiro
    Kuzushita, Noriyoshi
    Mita, Eiji
    Kato, Michio
    Miyoshi, Eiji
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (01) : 95 - 102
  • [9] Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
    Takahiro Maeda
    Hiroaki Kanzaki
    Tetsuhiro Chiba
    Junjie Ao
    Kengo Kanayama
    Susumu Maruta
    Yuko Kusakabe
    Tomoko Saito
    Kazufumi Kobayashi
    Soichiro Kiyono
    Masato Nakamura
    Sadahisa Ogasawara
    Eiichiro Suzuki
    Yoshihiko Ooka
    Shingo Nakamoto
    Ryo Nakagawa
    Ryosuke Muroyama
    Tatsuo Kanda
    Hitoshi Maruyama
    Naoya Kato
    BMC Cancer, 19
  • [10] Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma
    Zhoujing Zhang
    Shengxiang Ge
    Xiaomin Wang
    Quan Yuan
    Qiang Yan
    Huiming Ye
    Yaojian Che
    Yanyan Lin
    Jun Zhang
    Pingguo Liu
    Hepatology International, 2013, 7 : 199 - 207
12345